Provided by Tiger Fintech (Singapore) Pte. Ltd.

Academy Sports & Outdoors, Inc.

37.85
+1.203.27%
Post-market: 37.850.00000.00%19:11 EDT
Volume:1.58M
Turnover:59.43M
Market Cap:2.54B
PE:6.61
High:37.99
Open:36.84
Low:36.76
Close:36.65
Loading ...

Academy Sports & Outdoors Is Maintained at Hold by TD Cowen

Dow Jones
·
09 Jan

After a Disastrous Year, This Retailer's Stock Looks Ready to Pop -- Barrons.com

Dow Jones
·
08 Jan

CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones

GlobeNewswire
·
08 Jan

Loop Capital encouraged by price competitiveness at Academy Sports

TIPRANKS
·
07 Jan

Stoke Therapeutics Announces Alignment with Global Regulatory Agencies and Plans to Initiate a Phase 3 Study of Zorevunersen as Potentially the First Disease-Modifying Medicine for the Treatment of Dravet Syndrome

Business Wire
·
07 Jan

Stoke Therapeutics to Host Webcast to Discuss Successful Global Regulatory Alignment for a Phase 3 Study of Zorevunersen as Potentially the First Disease Modifying Medicine for Dravet Syndrome

Business Wire
·
07 Jan

Is it a Good Idea to Invest in Vanda Pharmaceuticals Stock Now?

Zacks
·
07 Jan

American Outdoor Up 89% in 6 Months: Buy, Sell or Hold the Stock?

Zacks
·
06 Jan

Academy Sports and Outdoors, Inc. (ASO): Is This Sporting Goods Stock A Good Buy Now?

Insider Monkey
·
31 Dec 2024

Reflecting On Specialty Retail Stocks’ Q3 Earnings: Ulta (NASDAQ:ULTA)

StockStory
·
30 Dec 2024

As Tariffs Loom, How One Retailer Aims to Keep Prices Low on Nikes and Asics -- WSJ

Dow Jones
·
23 Dec 2024

Academy Sports and Outdoors (NASDAQ:ASO) Takes On Some Risk With Its Use Of Debt

Simply Wall St.
·
22 Dec 2024

What Does Academy Sports and Outdoors, Inc.'s (NASDAQ:ASO) Share Price Indicate?

Simply Wall St.
·
20 Dec 2024

Sportsman’s Warehouse Holdings, Inc. (SPWH): A Bull Case Theory

Insider Monkey
·
20 Dec 2024

Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VGT-1849A, a Novel and Selective Antisense Oligonucleotide Candidate for the Treatment of Polycythemia Vera

PR Newswire
·
20 Dec 2024

Ultragenyx Announces First Patient Dosed in Pivotal Phase 3 Aspire Study Evaluating GTX-102 in Angelman Syndrome

GlobeNewswire
·
20 Dec 2024

Citigroup Initiates Coverage on Academy Sports and Outdoors With Buy Rating, $65 Price Target

MT Newswires Live
·
18 Dec 2024

Academy Sports initiated with a Buy at Citi

TIPRANKS
·
18 Dec 2024

Academy Sports’ quarter-to-date trends improving, says Goldman Sachs

TIPRANKS
·
18 Dec 2024

Bear of the Day: Academy Sports and Outdoors (ASO)

Zacks
·
17 Dec 2024